No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | 68,511 | 62,507 | 83,050 | 93,660 | 95,470 | 93,759 | 102,327 | N/A | N/A |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | 3,062 | 3,137 | 4,026 | 3,019 | 3,597 | 4,297 | 4,728 | N/A | N/A |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Godrej Agrovet Limited functions as a diverse agribusiness enterprise, providing products and solutions designed to enhance crop and livestock yields across India and internationally. Its operations are organized into key segments: Animal Feed, Crop Protection, Vegetable Oil, Real Estate, Seed Business, Wind Energy Generation, and Cattle Breeding. Within its Animal Feed division, the company supplies specialized nutritional feeds for cattle, poultry, and aquaculture. It is also a prominent participant in oil palm cultivation, managing approximately 75,000 hectares of plantations spanning Andhra Pradesh, Telangana, Tamil Nadu, Goa, Maharashtra, and Mizoram, from which it produces crude palm oil, crude palm kernel oil, and palm kernel cake. Furthermore, Godrej Agrovet manufactures and distributes a comprehensive range of crop protection items, including plant growth regulators, biostimulants, herbicides, insecticides, fungicides, and both chemical and organic fertilizers. The company also extends into the consumer market, offering poultry and meat products under the 'Real Good Chicken' brand, and a variety of ready-to-cook vegetarian and non-vegetarian items marketed as 'Godrej Yummiez'. Its dairy portfolio includes milk and milk products sold under the 'Godrej Jersey' label. Beyond these, Godrej Agrovet produces active ingredients, intermediates, bulk materials, and formulations for agrochemical applications, in addition to pharmaceutical intermediates. The company, established in Mumbai, India, in 1991, operates as a subsidiary of Godrej Industries Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Godrej Agrovet Limited (GODREJAGRO.NS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Godrej Agrovet Limited functions as a diverse agribusiness enterprise, providing products and solutions designed to enhance crop and livestock yields across India and internationally. Its operations are organized into key segments: Animal Feed, Crop Protection, Vegetable Oil, Real Estate, Seed Business, Wind Energy Generation, and Cattle Breeding. Within its Animal Feed division, the company supplies specialized nutritional feeds for cattle, poultry, and aquaculture. It is also a prominent participant in oil palm cultivation, managing approximately 75,000 hectares of plantations spanning Andhra Pradesh, Telangana, Tamil Nadu, Goa, Maharashtra, and Mizoram, from which it produces crude palm oil, crude palm kernel oil, and palm kernel cake. Furthermore, Godrej Agrovet manufactures and distributes a comprehensive range of crop protection items, including plant growth regulators, biostimulants, herbicides, insecticides, fungicides, and both chemical and organic fertilizers. The company also extends into the consumer market, offering poultry and meat products under the 'Real Good Chicken' brand, and a variety of ready-to-cook vegetarian and non-vegetarian items marketed as 'Godrej Yummiez'. Its dairy portfolio includes milk and milk products sold under the 'Godrej Jersey' label. Beyond these, Godrej Agrovet produces active ingredients, intermediates, bulk materials, and formulations for agrochemical applications, in addition to pharmaceutical intermediates. The company, established in Mumbai, India, in 1991, operates as a subsidiary of Godrej Industries Limited.
